Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/10/24 17:55 | 6/7/24 | MXCT | Health | Biolab | Commercial Physical & Biologi | Masoud Maher | MD | DO | P,CEO | P.m | 489 | 4.89 | 0 | 100 | New | 100 | D | ||||||||||||||
3/30/23 09:11 | 3/29/23 | MXCT | Health | BioPrd | Biological Products, (No Diag | Douglas Richard | MD | D | P | 345 | 4.32 | 0 | 80 | 400 | 100 | D | |||||||||||||||
11/23/21 07:46 | 11/22/21 | MXCT | Health | BioPrd | Biological Products, (No Diag | Douglas Richard | MD | D | P | 222 | 11.12 | 0 | 20 | New | 20 | D | |||||||||||||||
8/3/21 18:08 | 7/30/21 | MXCT | Health | Biolab | Commercial Physical & Biologi | Casdin Partners Master Fund, L.P. | NY | T | P | 23,400 | 13.00 | 0 | 1,800 | 15 | 13,971 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |